<h2 id="what-is-remifentanil-">What is Remifentanil? <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Ultra-short-acting synthetic opioid analgesic.</li>
  <li>Used for pain management and as an adjunct to anesthesia.</li>
  <li>Rapid onset and short duration of action.</li>
</ul>
<h2 id="mechanism-of-action--pharmacokinetics-">Mechanism of Action &amp; Pharmacokinetics <sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Acts primarily on mu-opioid receptors in the brain and spinal cord with minimal or no activity on delta and kappa opioid receptors.
    <ul>
      <li>The mu receptor is predominantly responsible for analgesia, hypoventilation, and euphoria</li>
    </ul>
  </li>
  <li>Rapidly metabolized by nonspecific esterases in blood and tissues, leading to quick clearance without redistribution.</li>
</ul>
<h2 id="pharmacodynamics-">Pharmacodynamics <sup id="fnref:1:2" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:1" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<h3 id="cardiovascular">Cardiovascular</h3>
<ul>
  <li>May decrease heart rate and blood pressure</li>
  <li>The degree of hypotension and bradycardia is dose-dependent, predictable, and quickly reversible due to rapid metabolism.</li>
</ul>
<h3 id="respiratory">Respiratory</h3>
<ul>
  <li>Can cause skeletal muscle and chest wall rigidity, particularly with continuous infusion, leading to decreased minute ventilation, respiratory depression, and apneas.</li>
</ul>
<h2 id="indications-">Indications <sup id="fnref:1:3" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Induction and maintenance of general anesthesia.</li>
  <li>Analgesia during short/intense surgical procedures.</li>
  <li>MAC sparing agent, reducing the MAC of inhalation anesthetics.</li>
</ul>
<h2 id="dosage-">Dosage <sup id="fnref:2:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li><strong>Bolus:</strong>
    <ul>
      <li>1-2 µg/kg IV bolus for sympathectomy during laryngoscopy and as a co-induciton agent.</li>
    </ul>
  </li>
  <li><strong>Analgesia during surgery:</strong>
    <ul>
      <li>0.5 to 1 µg/kg IV bolus.</li>
      <li>Followed by an infusion of 0.05 to 0.2 µg/kg/min.</li>
    </ul>
  </li>
</ul>
<h2 id="complications-">Complications <sup id="fnref:1:4" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:3" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup><sup id="fnref:3" role="doc-noteref"><a href="#fn:3" class="footnote" rel="footnote">3</a></sup></h2>
<ul>
  <li>Rapid onset and high potency can lead to pronounced hypotension, bradycardia, muscle rigidity, and respiratory depression or arrest.</li>
  <li>Common opioid-related side effects include nausea, vomiting, pruritus, and postoperative shivering.</li>
  <li>Due to its rapid offset, there is a risk of postoperative hyperalgesia if not bridged with longer-acting analgesics upon discontinuation.</li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Birdi T, Sullivan P. Ottawa Anesthesia Primer. Toronto, Ontario: Echo Book Publishing; 2012. <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:1:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:1:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a> <a href="#fnref:1:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <p><a href="https://www.uptodate.com/contents/remifentanil-drug-information?search=remifentanil&amp;source=panel_search_result&amp;selectedTitle=1%7E101&amp;usage_type=panel&amp;kp_tab=drug_general&amp;display_rank=1">Remifentanil: Drug Information. UpToDate.</a> <a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:2:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:2:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:2:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a></p>
    </li>
    <li id="fn:3" role="doc-endnote">
      <p>Rosow, Carl E. (1999). An overview of remifentanil. <em>Anesthesia &amp; Analgesia, 89</em>(4S): 1. DOI: 10.1097/00000539-199910001-00001. <a href="#fnref:3" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>